Overview

Cocaine Abuse and ADHD - 10

Status:
Completed

Trial end date:
1998-03-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate the safety and efficacy of buproprion in treating individuals with adult attention-deficit hyperactivity disorder (ADHD) and cocaine dependence.

Phase:

Phase 2

Details

Lead Sponsor:

National Institute on Drug Abuse (NIDA)

Collaborator:

New York State Psychiatric Institute

Treatments:

Cocaine
Flupenthixol
Flupenthixol decanoate